InsidersTradesSigma
Follow the HEM파마 stock price and the full directors' dealings record of the company, a listed issuer based in South Korea. Shares trade on the KR market, under the oversight of DART (FSS). Operating in the Health Care sector, HEM파마 has recorded 30 insider filings. Market capitalisation: €289.6bn. The latest transaction was reported on 13 July 2026 (Purchase). Among the most active insiders: 지요셉. Every trade is accessible without an account.
28
Insider Decl.
n/a
Thresholds
n/a
13 ops.
Buy Volume
n/a
11 ops.
Sell Volume
Fundamental score
Ranked 28,349 of 29,024 companies
10.8
score / 100
Value19
Quality3
FCF yld-6.3%
Earn yld-8.2%
EV/EBITDA·
ROE-194%
Gross mgn4.9%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 13 July 2026
Declarations30 total
Other
Other
25 of 30 declarations
About HEM파마
HEM파마 is a company operating in the health and pharmaceutical sector, listed on the XKRX market. It specializes in the development and distribution of pharmaceutical products.